Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia
BMC Microbiology · 17.05.2024 · 24 (1)
DOI: 10.1186/s12866-024-03329-x ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 17.05.2024. Verfasst von Tianjin Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230032, Chin…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Gastrointestinal Microbiome, Dyslipidemias, Dysbiosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is an endocrinopathy in childbearing-age females which can cause many complications, such as diabetes, obesity, and dyslipidemia. The metabolic disorders in patients with PCOS were linked to gut microbial dysbiosis. However, the correlation between the gut microbial community and dyslipidemia in PCOS remains unillustrated. Our study elucidated the different gut microbiota in patients with PCOS and dyslipidemia (PCOS.D) compared to those with only PCOS and healthy women.
Results
In total, 18 patients with PCOS, 16 healthy females, and 18 patients with PCOS.D were enrolled. The 16 S rRNA sequencing in V3-V4 region was utilized for identifying the gut microbiota, which analyzes species annotation, community diversity, and community functions. Our results showed that the β diversity of gut microbiota did not differ significantly among the three groups. Regarding gut microbiota dysbiosis, patients with PCOS showed a decreased abundance of Proteobacteria, and patients with PCOS.D showed an increased abundance of Bacteroidota compared to other groups. With respect to the gut microbial imbalance at genus level, the PCOS.D group showed a higher abundance of Clostridium_sensu_stricto_1 compared to other two groups. Furthermore, the abundances of Faecalibacterium and Holdemanella were lower in the PCOS.D than those in the PCOS group. Several genera, including Faecalibacterium and Holdemanella , were negatively correlated with the lipid profiles. Pseudomonas was negatively correlated with luteinizing hormone levels. Using PICRUSt analysis, the gut microbiota community functions suggested that certain metabolic pathways (e.g., amino acids, glycolysis, and lipid) were altered in PCOS.D patients as compared to those in PCOS patients.
Conclusions
The gut microbiota characterizations in patients with PCOS.D differ from those in patients with PCOS and controls, and those might also be related to clinical parameters. This may have the potential to become an alternative therapy to regulate the clinical lipid levels of patients with PCOS in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
- NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, 230032, China.
- Ministry of Education Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, 230032, China.
- Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei, 230032, China.
- Biopreservation and Artificial Organs, Anhui Provincial Engineering Research Center, Anhui Medical University, Hefei, 230032, China.
- NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, 230032, China. hxj0117@126.com.
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Yang, T., Li, G., Xu, Y., He, X., Song, B., & Cao, Y. (2024). Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03329-x
Vancouver
Yang T, Li G, Xu Y, He X, Song B, Cao Y. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03329-x
BibTeX
@article{Yang2024,
author = {Yang, Tianjin and Li, Guanjian and Xu, Yuping and He, Xiaojin and Song, Bing and Cao, Yunxia},
title = {Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia},
journal = {BMC Microbiology},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12866-024-03329-x}
}
EUVIMED